Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

NASDAQ:EWTX

Overview | Financials
Company Name Edgewise Therapeutics, Inc.
Symbol EWTX
Currency USD
Price 18.11
Market Cap 1,691,452,268
Dividend Yield 0%
52-week-range 5.12 - 21.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Kevin Koch Ph.D.
Website https://www.edgewisetx.com

An error occurred while fetching data.

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops

Related Stocks

LianBio logo

LianBio

LIAN

0.319 USD

Zynex, Inc. logo

Zynex, Inc.

ZYXI

10.88 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

10.54 USD

Radius Health, Inc. logo

Radius Health, Inc.

RDUS

18.89 USD

Eiger BioPharmaceuticals, Inc. logo

Eiger BioPharmaceuticals, Inc.

EIGR

1.725 USD

Aadi Bioscience, Inc. logo

Aadi Bioscience, Inc.

AADI

1.91 USD

Financials

Numbers are in millions USD

Numbers are in millions USD